Abstract
Numerous studies have shown that nanosized zeolitic imidazolate framework particles (ZIF-8 NPs) serve as promising vehicles for pH-responsive drug delivery. An understanding of their interaction with serum proteins present in physiological systems will thus be of critical importance. In this work, monodisperse ZIF-8 NPs with an average size of 60 nm were synthesized at room temperature and characterized for their various physicochemical properties. Bovine serum albumin (BSA) was used as model serum protein for various interaction studies with ZIF-8 NPs. Spectroscopic techniques such as UV–visible and fluorescence spectroscopy indicated the formation of a ground-state complex with a binding constant of the order 103 M−1 and a single binding site. Steady-state and time-resolved fluorescence spectroscopy confirmed the mechanism of quenching to be static. Conformational changes in the secondary structure of BSA were observed using CD and FT-IR spectroscopies. Binding sites were explored using molecular docking studies.
Subject terms: Chemistry, Nanoscience and technology
Introduction
Metal–organic frameworks (MOFs) or porous coordination polymers (PCPs) are a class of coordination compounds in which metal ion vertices are interconnected by organic linkers to give highly porous structures with large internal surface area1. Zeolitic imidazolate frameworks (ZIFs) are a subclass of MOFs, structurally similar to conventional aluminosilicate zeolites, made up of M–Im–M type linkages (M = Zn or Co, Im = Imidazolate)2. One of the most studied ZIFs is ZIF-8, consisting of zinc metal ions and 2-methyl imidazolate (2-mIm) linkers. Both the constituents are found in physiological systems, zinc being the second most abundant transition element found in biological systems and the imidazole group an integral part of the amino acid histidine, making ZIF-8 highly biocompatible3. Nanosized ZIF-8 particles (ZIF-8 NPs) have been reported as efficient drug delivery systems owing to their properties such as (1) high surface area (BET: 1630 m2 g−1) and large pore size (11.6 Å), (2) high chemical and thermal stability, (3) high drug loading capacity and small window size (3.4 Å) preventing premature release of drug, (4) good dispersibility, and (5) pH-responsive drug release4–7. The protonation of the imidazolate group at pH 5.0–6.0 results in dissociation of the bond between zinc and imidazolate, thereby disassembling the nanostructure, which is ideal for drug release at tumor sites where the microenvironment is more acidic (pH 5.0–6.8) than in blood circulation and healthy tissues8.
Once nanoparticles are delivered within the body, they physically interact with biological macromolecules, particularly serum proteins present in blood and other body fluids9. Serum albumins account for almost 55% of the serum proteins present in the blood plasma10. Being naturally abundant in the blood, serum albumins are responsible for major functions such as maintenance of blood pH and osmotic pressure, and transportation of various endogenous-exogenous substances owing to their flexibility and ability to bind both hydrophilic and hydrophobic groups11,12. Bovine serum albumin (BSA) is one of the most studied serum albumins. It is a globular-protein and considered to be homologous to human serum albumin (HSA) with high sequence identity (> 70%)13. It is an inexpensive analog of HSA and more easily available. BSA consists of 583 amino acid residues divided amongst three structurally homologous domains (I, II, III) which are further divided into sub-domains14. There are two tryptophan residues (Trp134, Trp213) present, imparting BSA with intrinsic fluorescence15. Interactions between BSA and various noble metal NPs (such as Au, Ag)16,17, metal oxide NPs (such as ZnO, TiO2, CuO, iron oxide)18–21, ferrite NPs (such as manganese and cobalt ferrite)22,23, quantum dots24,25, etc., have been investigated. As per our knowledge, ZIF-8 NPs till now have not been systematically explored for their possible interaction with proteins, particularly BSA. An insight into this would be beneficial for future biomedical applications of these NPs.
In this work, we first synthesized ZIF-8 NPs and determined their various physicochemical properties. To investigate the interactions with BSA, we opted for a multi-spectroscopic and molecular docking approach. We employed UV–visible spectroscopy, along with steady-state and time-resolved fluorescence spectroscopies to determine binding constants between NPs and the protein. Circular Dichroism (CD) spectroscopy and Fourier-Transform Infrared (FT-IR) spectroscopy were employed to study conformational changes in the secondary structure of the protein upon binding. Molecular docking was performed to determine the binding sites and specific molecular interactions present between the NPs and different binding sites of BSA.
Results and discussion
Characterization of ZIF-8 NPs
Both TEM and SEM images of the as-synthesized ZIF-8 nanoparticles indicated the presence of monodispersed spherical particles with an average diameter of 60 nm (Fig. 1a–c). The synthesis conditions and time dictate the morphology of the nanoparticles. In our case, spherical nanoparticles were obtained as a result of a less reaction time of 5 min, whereas several other studies have reported rhombic dodecahedral shaped particles involving larger reaction time (12 h or more)26,27. The hydrodynamic diameter of the particles using DLS measurements was found to be 211.9 nm with a low polydispersity index (PDI) of 0.025, confirming formation of uniform particles (Fig. 1d). Since the hydrodynamic size is estimated by considering the hydration layer present on the particle surface, it is greater than the average size obtained from TEM analysis. Elemental analysis using EDS confirmed the presence of Zn, C, and N (Fig. 1e). The surface charge (zeta potential), measured at pH 7.0 (neutral) and 5.8 (weakly acidic), were + 21.1 mV and + 22.9 mV, respectively. The positive zeta-potential values can be attributed to the presence of excess zinc ions on the particle surface.
The FT-IR spectrum confirmed the successful synthesis of ZIF-8 NPs (Fig. 2a). The weak bands at 3138 and 2933 cm−1 are assigned to aromatic and aliphatic C–H stretch, respectively, of the imidazole group. The peak at 1585 cm−1 is attributed to C=N stretching and the intricated bands between 1350 and 1500 cm−1 are due to imidazole ring stretching. Bands in the region 900–1350 cm−1 and those below 850 cm−1 are associated with in-plane and out-of-plane bending of the imidazole ring, respectively. A strong band at 420 cm−1 is linked to Zn–N stretching28. Crystallinity and sodalite topology of ZIF-8 NPs was confirmed by XRD pattern (Fig. 2b). Comparison to simulated XRD pattern indicated the formation of pure-phase nanoparticles29. From the TGA plot (Fig. 2c), it was observed that there was a very small percentage of weight loss up to about 400 °C, indicating high thermal stability of as-formed nanoparticles. Beyond 400 °C, the weight loss is due to the decomposition of the 2-methylimidazole molecules27.
Binding studies between ZIF-8 NPs and BSA
UV–visible spectroscopy
UV–visible spectroscopy is a powerful tool to study changes in protein conformation upon binding with a ligand. BSA shows two absorption peaks, a stronger peak at 210 nm reflecting framework conformation and another peak at 278 nm due to π → π* transition of aromatic amino acid residues (mainly Tyr, Trp)30. These absorption values may shift in magnitude and direction upon transfer of the chromophore to a different micro-environment, which tends to alter as a result of a change in protein conformation. The changes in the absorbance spectrum at 278 nm are generally observed for studying the binding interaction of proteins with ligands. It was observed, that on increasing the concentration of added ZIF-8 NPs to BSA, absorbance values at 278 nm increased, confirming the formation of a ground-state complex (Fig. 3a). Non-bonding interactions between a protein and a ligand can be quantitatively estimated using the Benesi–Hildebrand equation31,32. We used this equation to find the binding constant between BSA and ZIF-8 NPs.
Here, Aobs and Ao denote the absorbance values at 278 nm in the presence and absence of ZIF-8 NPs, respectively. Ac is the maximum absorbance value in presence of nanoparticles and kapp is apparent binding constant. The corresponding plot gave binding constant value of 0.28 × 103 M−1 (Fig. 3b). These results were suggestive of changes in protein conformation due to the formation of a stable complex between ZIF-8 NPs and BSA.
Steady-state fluorescence spectroscopy
Various molecular interactions such as molecular-rearrangements, energy transfer, excited-state reactions, collision among molecules, and formation of ground-state complex may result in a decrease in fluorescence intensity of a fluorophore33. There are three intrinsic fluorophores present in BSA: phenylalanine, tyrosine, and tryptophan. Due to the low fluorescence quantum yield of phenylalanine, and very high quenching of tyrosine fluorescence in presence of an amino or carboxyl group, tryptophan is considered as the prime contributor towards intrinsic fluorescence of BSA34. The fluorescence intensity of tryptophan residues present in BSA is highly sensitive to a change in their micro-environment (hydrophobicity and polarity), and therefore can be used as an endogenous probe to monitor binding interactions. Analysis of fluorescence quenching of BSA in presence of ZIF-8 NPs showed a decrease in fluorescence intensity on increasing the concentration of nanoparticles (Fig. 4a). This fluorescence quenching can be a result of collisions between the fluorophore and the nanoparticles/quencher (dynamic quenching) or due to formation of a ground-state complex (static quenching). To verify the mechanism of quenching, we used the well-known Stern–Volmer equation35.
Here, Fo and F represent BSA fluorescence intensity in the absence and presence of quencher, Q (ZIF-8 NPs), respectively. Ksv is the Stern–Volmer quenching constant, Kq the quenching constant, and τo the average fluorescence lifetime (10−8 s for BSA). The plot between Fo/F and concentration of ZIF-8 NPs (Fig. 4b) gave a value of 3.13 × 10−2 M−1 for Ksv, and a corresponding value of 3.13 × 1010 M−1 s−1 for Kq. The observed value for Kq is higher than the maximum value of the collision quenching constant (2.0 × 1010 M−1 s−1), confirming static quenching due to the formation of a ground-state complex between BSA and ZIF-8 NPs. The ground-state complex formed is stabilized mainly by one or more non-covalent binding forces, such as van der waals forces, hydrogen bonding, hydrophobic interactions, and electrostatic interactions36.
The static binding constant (Kb) and the number of binding sites (n) were determined using the double-logarithmic plot (Fig. 4c) based on modified Stern–Volmer equation37.
The value for the number of binding sites from the plot came out to be 1.09, indicating a single binding site present in BSA for nanoparticles. The binding constant between ZIF-8 NPs and BSA was found to be 0.59 × 103 M−1. The results from fluorescence quenching measurements are therefore in agreement with our observations in changes in UV–visible spectra of protein upon addition of nanoparticles. Dynamic quenching does not affect the absorption spectrum of the protein; however, formation of ground-state complex due to static quenching is reflected by changes in both fluorescence and UV–visible absorption spectra.
Time-resolved fluorescence spectroscopy
Measurement of decay in fluorescence lifetimes can also help in ascertaining the nature of fluorescence quenching. In the process of dynamic quenching, a decrease in average-lifetime value of fluorophore is observed. Whereas, in case of static quenching no change in lifetime value of fluorophore (un-complexed) is observed due to formation of non-fluorescent complex38. The two tryptophan residues present in BSA are in different local environments; Trp134 is on the surface and Trp213 is deeply buried39. BSA did not show any considerable change in fluorescence with time with the addition of ZIF-8 NPs (Fig. 5). Two exponentials, τ1 and τ2, were used for fluorescence decay curve fitting. Average-lifetime values (τav) were obtained from lifetime values (τ1, τ2), pre-exponential values (a1, a2) and normalized pre-exponential values (α1, α2) (Table 1)40.
Table 1.
[ZIF-8 NPs] (mM) | τ1 (ns) | τ2 (ns) | a1 | a2 | τav (ns) |
---|---|---|---|---|---|
0 | 3.80 | 6.68 | 0.035 | 0.105 | 5.96 |
0.058 | 3.73 | 6.66 | 0.031 | 0.109 | 6.01 |
0.116 | 3.57 | 6.63 | 0.028 | 0.112 | 6.02 |
0.172 | 3.34 | 6.67 | 0.028 | 0.111 | 6.00 |
0.228 | 3.41 | 6.64 | 0.026 | 0.114 | 6.04 |
0.283 | 3.67 | 6.73 | 0.036 | 0.106 | 5.95 |
A considerable difference between values of τ1 and τ2 confirmed presence of two tryptophan residues in different microenvironments. Also, fairly constant average-lifetime values in the presence and absence of ZIF-8 NPs confirmed static quenching as the formation of a complex does not alter the lifetime values41.
Circular dichroism (CD) spectroscopy
CD spectroscopy in the far UV region can be utilized for studying changes in secondary structure of a protein. BSA is an α-helix rich protein. The characteristic CD spectrum of BSA shows two negative bands at 208 and 222 nm corresponding to π → π* and n → π* electronic transitions, respectively for α-helix secondary structure42. Any change in position and intensity of these bands indicates change in conformation of the protein upon binding. On addition of ZIF-8 NPs, a decrease in magnitude of molar ellipticity values with a slight shift in peak position was observed (Fig. 6). Mean residual ellipticity values (MRE) (deg cm2 dmol−1) at 208 nm were obtained from observed molar ellipticity values (deg), which were then used to determine α-helix content (%) in BSA, with and without added NPs43.
Here, Cp denotes molar concentration of BSA, l is cuvette path length (1 cm), and n is amino acid residues present (583 for BSA). A decrease in α-helix content was observed in presence of NPs (Table 2). This decrease was indicative of change in protein conformation due to insertion of nanoparticle into the binding site of protein. The hydrogen bonding network present in α-helical structure of the protein is perturbed due to interaction of particle with amino acid residues present in the binding cleft44. The characteristics peaks corresponding to α-helix secondary structures are retained, however, lower in intensity, suggesting some unfolding of the protein without any destructive conformation changes. These results are consistent with the results of fluorescence and UV–visible spectroscopy.
Table 2.
[ZIF-8 NPs] (µM) | % α-helix |
---|---|
0 | 38.6 |
67.6 | 31.1 |
Fourier-transform infrared (FT-IR) spectroscopy
Characteristic amide-I (1600–1700 cm−1) and amide-II (1500–1600 cm−1) bands in the mid-IR region are associated with secondary structure of a protein. Amide-I band is linked to C=O stretching, while amide-II band is mainly attributed to coupling between C–N stretching and N–H bending and less influenced by a change in the structure45. BSA showed a significant shift in position of amide-I band from 1639 to 1650 cm−1 and a very slight shift in position of amide-II band from 1548 to 1550 cm−1 upon interaction with ZIF-8 NPs in the FT-IR spectrum (Fig. 7). The significant shift in position of amide-I band due to stretching of C=O can be possibly explained on the basis of hard and soft acid base (HSAB) theory. This theory can help in predicting the selective interaction between metal ions and functional groups present at the binding sites of protein. Metal ions preferentially bind to protein sites having similar hardness or softness46. Zinc ion (Zn2+; present in ZIF-8 NPs) is a borderline acid and C=O group is a soft base. Their interaction will result in conformational changes in the secondary structure of the protein, which can be reflected in the changes in the position of amide bands of BSA upon addition of ZIF-8 NPs.
Molecular docking
The secondary building units (SBUs) present in MOFs are metal ion clusters joined to each other by organic linkers. These lock the position of metal ion into a fixed geometry, giving a rigid framework. The SBU of ZIF-8 (Fig. 8a), consisting of zinc ion tetrahedrally linked to four 2-methyl imidazole groups, was chosen for studying the interaction of ZIF-8 NPs with BSA. This is the basic unit for ZIF-8 NPs, as linking of these SBUs to one another results in formation of three-dimensional network of ZIF-8. Three-dimensional structure of BSA (Fig. 8b) shows presence of mainly α-helices. The complex of protein with ZIF-8 unit (Fig. 9) shows that ZIF-8 fits in the cavity of protein chain. The values for interface area and atomic contact energy were obtained to be 736.70 Å2 and 113.29 kcal mol−1, respectively, indicating strong binding. Seven amino acid residues were involved in binding (Lys114, Arg144, His145, Arg185, Leu189, Ile141, Pro110). The amino acid residues Leu 189, Ile141 and Pro110 have hydrophobic side chains; whereas Lys114, Arg144, Arg185 and His145 have positively charged groups. It can be inferred that the binding between ZIF-8 unit and BSA is mainly due to hydrophobic interactions, with some minor contribution from electrostatic interactions.
For molecular docking studies, we considered a single SBU of ZIF-8, instead of a full nanoparticle. We assumed that even if there are many SBUs in the ligand file, their binding with the protein will be at some specific region (binding cavity) only. Moreover, even after adding more repeating units, there will not be any significant change in the binding free energy; possibly due to the reason that the binding groove of the protein is already occupied with the single repeating unit of the nanoparticle. Although the role of nanoparticle morphology and the structural changes in protein upon binding cannot be deciphered by this docking approach, it gives vital information about the binding process. It confirms that the binding is taking place with appreciable interface area and atomic contact energy. It further reveals the possible binding site in the protein and the amino acids responsible for interaction. These findings from molecular docking validated the previously obtained results from spectroscopic techniques. The binding of ZIF-8 unit in the protein cavity will disrupt the α-helix secondary structure, which explains the observations made in the far-UV CD and FT-IR spectra of BSA. The resulting change in protein conformation will affect the micro-environment of the nearby tryptophan residues. Also, the presence of substantial binding between ZIF-8 SBU and BSA confirms that there is formation of a ground state-complex and is in accordance with the results obtained from UV–visible and fluorescence spectroscopic studies.
Material and methods
Materials
Zinc nitrate hexahydrate (Zn(NO3)2·6H2O, 99%) with CAS number 10196-18-6, bovine serum albumin (BSA, ≥ 98%) with CAS number 9048-46-8, and 1× phosphate buffered saline (PBS, pH = 7.4 ± 0.1) were obtained from Sisco Research Laboratories (SRL) Pvt. Ltd., India. 2-Methyl imidazole (C4H6N2, ≥ 99%) with CAS number 693-98-1, was procured from Central Drug House (CDH) (P) Ltd., India. Methanol (HPLC grade) was purchased from Spectrochem Pvt. Ltd., India. All chemicals were used as received, without any further purification.
Synthesis of ZIF-8 NPs
Nanosized ZIF-8 particles were synthesized according to a previous report47. A solution containing 150 mg zinc nitrate hexahydrate dissolved in 7.15 mL of methanol was kept for magnetic stirring at room temperature. To this, a solution containing 330 mg 2-Methyl Imidazole dissolved in 7.15 mL methanol was added dropwise under constant stirring. After stirring for 5 min, the reaction solution became milky white indicating the formation of nanoparticles. The particles were separated by centrifuging at 8000 rpm and unreacted reagents were removed subsequently by washing with methanol. The particles were then dried for further analysis.
Characterization of ZIF-8 NPs
The as-prepared ZIF-8 NPs were characterized for their physicochemical properties before carrying out interaction studies. The size and morphology of the particles were determined using transmission electron microscopy (TEM), scanning electron microscopy (SEM), and dynamic light scattering (DLS) measurements. A dilute sample of ZIF-8 NPs dispersed in methanol was drop casted on carbon-coated copper grids, followed by air-drying and analysis using TALOS TEM (Thermo Scientific) operating at 200 kV. Nanoparticles dispersed in methanol were drop casted on a glass slide and air-dried, and then SEM analysis was carried out using JEOL JSM-6610 operating at 20 kV. Nanoparticles were well dispersed in water and the Malvern Zetasizer instrument was used for DLS and zeta potential analysis. Elemental composition was verified by energy dispersive spectroscopy (EDS) using JEOL JSM-6610 instrument. Fourier-transform infrared (FT-IR) spectroscopy was used to analyze surface functionalities using Shimadzu IRAffinity-1S spectrophotometer. Shimadzu DTG-60 simultaneous DTA-TG apparatus was used for thermogravimetric analysis (TGA) of nanoparticles in nitrogen atmosphere. The crystallinity of particles was determined using the Rigaku Miniflex benchtop powder X-ray diffraction (XRD) instrument.
Binding studies between ZIF-8 NPs and BSA
UV–visible spectroscopy
Stock solutions of BSA (15 μM, in PBS) and ZIF-8 NPs (2 mg/mL, 8.8 mM, in methanol) were prepared. UV–visible spectra were recorded using Lab India UV 3092 spectrophotometer in the wavelength range of 200–400 nm. The concentration of BSA was kept constant at 15 μM and the concentration of NPs was varied from 0 to 0.65 mM with a fixed incubation time of 1 min. Absorbance values at 278 nm were recorded and were used to determine the binding constant between the particles and protein by plotting the Benesi-Hildebrand graph.
Steady-state fluorescence spectroscopy
Fluorescence spectra were recorded using a Hitachi F-4700 fluorescence spectrophotometer by setting excitation wavelength at 278 nm for BSA and fluorescence intensity values were recorded at an emission wavelength of 340 nm. The concentration of BSA (in PBS) was kept constant at 15 μM and the concentration of NPs was varied from 0 to 0.65 mM during successive measurements with a fixed incubation time of 1 min. Emission values obtained were used to determine the nature of quenching by using the Stern–Volmer equation. The number of binding sites and binding constant was determined using a double-logarithmic plot.
Time-resolved fluorescence spectroscopy
The decay in fluorescence of BSA with time was observed using Horiba-Jobin Yvon spectrometer with nanoLED set at 280 nm providing excitation pulse of 1.2 ns and 1 MHz pulse repetition rate. All spectra were recorded at room temperature and decay in lifetime was measured using time-correlated single-photon counting, TCSPC technique. Prompt spectrum was recorded followed by lifetime measurements for protein by keeping the concentration of BSA constant (15 μM, in PBS) and varying the concentration of ZIF-8 NPs.
Circular dichroism (CD) spectroscopy
Conformational analysis was carried out by recording circular dichroism data for BSA (0.5 μM, in PBS), with and without NPs, using the Jasco J815 CD spectro-polarimeter. Quartz cuvette (path length, 1 cm) was used for all measurements, and nitrogen was fluxed continuously throughout the experiment. Baseline correction was done using PBS. An average of three scans was taken for each spectrum and recorded in the far UV region (190–250 nm) at 298 K with a response time of 1 s, scanning speed of 100 nm min−1, and bandwidth of 1 nm.
Fourier-transform infrared (FT-IR) spectroscopy
FT-IR spectra were recorded using Shimadzu IRAffinity-1S spectrophotometer in the spectral range of 1400–1800 cm−1. Spectra of BSA was recorded in presence and absence of ZIF-8 NPs. Concentration of BSA was kept constant at 1 mM (in PBS). For interaction study, concentration of NPs was taken as 5 mM and the sample was allowed to equilibrate for 1 h at room temperature.
Molecular docking
The crystallographic information file (.CIF) for ZIF-8 was obtained from structural database of CCDC (deposit number 864309). It was converted into .mol format using an open-source software, Open Babel. This file was then utilized to draw secondary building unit (SBU) of ZIF-8 in ChemDraw and saved in .mol format. Open Babel was again used to convert this file into .pdb format. The database of the Protein Data Bank was used for deriving the structure of BSA (ID-4O30) in .pdb format. BSA is made up of two identical chains. Chain A was selected for docking. The visualization software, UCSF Chimera-1.15 was used to view three-dimensional structure of the protein chain and the ZIF-8 SBU. The PatchDock molecular docking server, based on principles of shape-complementarity, was used48. The .pdb files of receptor (BSA) and ligand (ZIF-8) were uploaded with cluster RMSD value, 1.5 Å and protein-small ligand setting in complex type. The lowest energy docked complex was then analyzed for possible binding sites and visualized using UCSF Chimera.
Conclusion
The increasing research on the use of nanoparticles for biomedical applications demands extensive investigation of the interactions of nanoparticles with the constituents present in blood and other body fluids. The binding of nanoparticles with serum albumins present in the blood is responsible for their in vivo transportation, absorption, and distribution, which ultimately affects their stability, therapeutic efficacy, and toxicity. In the present study, we have observed the formation of a 1:1 ground-state complex between the nanoparticles and the protein, with a binding constant of the order 103 M−1. The static nature of the quenching mechanism also indicated binding of ZIF-8 NPs with the protein.
Binding of the common serum protein BSA on ZIF-8 surface can significantly alter the pharmacokinetics, biodistribution and degradation profile of the nanoparticle. In drug delivery, such interactions are often detrimental to the optimal performance of the nanoparticle. For example, increased size of protein-bound nanoparticles can lead to their enhanced phagocytic capture and degradation. In the case of ZIF-8 nanoparticles, such protein binding can hamper with their pH-controlled drug release property. Therefore, the surface of these nanoparticles should be extensively functionalized to reduce their hydrophobicity and/or cationic charge, so that non-specific protein binding is reduced. Further comprehensive studies will be useful in understanding the biological effects of these nanoparticles and their possible use as drug delivery vehicles for clinical studies in the future.
Acknowledgements
This study was supported by Faculty Research Programme (FRP 2021-22) grant provided by the Institution of Eminence (IoE), University of Delhi, India. Ashi Mittal acknowledges fellowship support from University Grants Commission (UGC), Government of India.
Author contributions
A.M., S.G. and I.R. conceived the study; A.M. carried out most of the experiments and wrote the initial draft of the manuscript; S.G. carried out molecular docking studies; S.G. and I.R. critically reviewed and edited the final manuscript.
Data availability
The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
These authors contributed equally: Ashi Mittal and Sona Gandhi.
References
- 1.Zhou HC, Long JR, Yaghi OM. Introduction to metal–organic frameworks. Chem. Rev. 2012;112:673–674. doi: 10.1021/cr300014x. [DOI] [PubMed] [Google Scholar]
- 2.Chen B, Yang Z, Zhu Y, Xia Y. Zeolitic imidazolate framework materials: Recent progress in synthesis and applications. J. Mater. Chem. A. 2014;2:16811–16831. doi: 10.1039/C4TA02984D. [DOI] [Google Scholar]
- 3.Broadley MR, White PJ, Hammond JP, Zelko I, Lux A. Zinc in plants. New Phytol. 2007;173:677–702. doi: 10.1111/j.1469-8137.2007.01996.x. [DOI] [PubMed] [Google Scholar]
- 4.Phan A, et al. Synthesis, structure, and carbon dioxide capture properties of zeolitic imidazolate frameworks. Acc. Chem. Res. 2010;43:58–67. doi: 10.1021/ar900116g. [DOI] [PubMed] [Google Scholar]
- 5.Lu G, et al. Imparting functionality to a metal–organic framework material by controlled nanoparticle encapsulation. Nat. Chem. 2012;4:310–316. doi: 10.1038/nchem.1272. [DOI] [PubMed] [Google Scholar]
- 6.Sun CY, et al. Zeolitic imidazolate framework-8 as efficient pH-sensitive drug delivery vehicle. Dalton Trans. 2012;41:6906–6909. doi: 10.1039/c2dt30357d. [DOI] [PubMed] [Google Scholar]
- 7.Venna SR, Jasinski JB, Carreon MA. Structural evolution of zeolitic imidazolate framework-8. J. Am. Chem. Soc. 2010;132:18030–18033. doi: 10.1021/ja109268m. [DOI] [PubMed] [Google Scholar]
- 8.Jung J, Lee IH, Lee E, Park J, Jon S. pH-sensitive polymer nanospheres for use as a potential drug delivery vehicle. Biomacromol. 2007;8:3401–3407. doi: 10.1021/bm700517z. [DOI] [PubMed] [Google Scholar]
- 9.Monopoli MP, Åberg C, Salvati A, Dawson KA. Biomolecular coronas provide the biological identity of nanosized materials. Nat. Nanotechnol. 2012;7:779–786. doi: 10.1038/nnano.2012.207. [DOI] [PubMed] [Google Scholar]
- 10.Colmenarejo G, Alvarez-Pedraglio A, Lavandera JL. Cheminformatic models to predict binding affinities to human serum albumin. J. Med. Chem. 2001;44:4370–4378. doi: 10.1021/jm010960b. [DOI] [PubMed] [Google Scholar]
- 11.He XM, Carter DC. Atomic structure and chemistry of human serum albumin. Nature. 1992;358:209–215. doi: 10.1038/358209a0. [DOI] [PubMed] [Google Scholar]
- 12.Kosa T, Maruyama T, Otagiri M. Species differences of serum albumins: II. Chemical and thermal stability. Pharm. Res. 1998;15:449–454. doi: 10.1023/A:1011932516717. [DOI] [PubMed] [Google Scholar]
- 13.Chruszcz M, et al. Serum albumins-unusual allergens. Biochim. Biophys. Acta Gen. Subj. 2013;1830:5375–5381. doi: 10.1016/j.bbagen.2013.06.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Bhuiya S, Pradhan AB, Haque L, Das S. Molecular aspects of the interaction of iminium and alkanolamine forms of the anticancer alkaloid chelerythrine with plasma protein bovine serum albumin. J. Phys. Chem. B. 2016;120:5–17. doi: 10.1021/acs.jpcb.5b07818. [DOI] [PubMed] [Google Scholar]
- 15.Samari F, Hemmateenejad B, Shamsipur M, Rashidi M, Samouei H. Affinity of two novel five-coordinated anticancer Pt(II) complexes to human and bovine serum albumins: A spectroscopic approach. Inorg. Chem. 2012;51:3454–3464. doi: 10.1021/ic202141g. [DOI] [PubMed] [Google Scholar]
- 16.Mariam J, Dongre PM, Kothari DC. Study of interaction of silver nanoparticles with bovine serum albumin using fluorescence spectroscopy. J. Fluoresc. 2011;21:2193–2199. doi: 10.1007/s10895-011-0922-3. [DOI] [PubMed] [Google Scholar]
- 17.Alsamamra H, Hawwarin I, Abu-Sharkh S, Abuteir M. Study the interaction between gold nanoparticles and bovine serum albumin: Spectroscopic approach. J. Bioanal. Biomed. 2018;10:43–49. doi: 10.4172/1948-593X.1000203. [DOI] [Google Scholar]
- 18.Bhogale A, et al. Systematic investigation of the interaction of bovine serum albumin with ZnO nanoparticles using fluorescence spectroscopy. Colloids Surf. B Biointerfaces. 2013;102:257–264. doi: 10.1016/j.colsurfb.2012.08.023. [DOI] [PubMed] [Google Scholar]
- 19.Ranjan S, Dasgupta N, Srivastava P, Ramalingam C. A spectroscopic study on interaction between bovine serum albumin and titanium dioxide nanoparticle synthesized from microwave-assisted hybrid chemical approach. J. Photochem. Photobiol. B Biol. 2016;161:472–481. doi: 10.1016/j.jphotobiol.2016.06.015. [DOI] [PubMed] [Google Scholar]
- 20.Abraham S, Vellaichamy P. Interaction of copper oxide nanoparticles with bovine serum albumin by spectroscopic studies. Int. J. Pharm. Pharm. Sci. 2018;10:35–38. doi: 10.22159/ijpps.2018v10i5.24877. [DOI] [Google Scholar]
- 21.Yang Q, Liang J, Han H. Probing the interaction of magnetic iron oxide nanoparticles with bovine serum albumin by spectroscopic techniques. J. Phys. Chem. B. 2009;113:10454–10458. doi: 10.1021/jp904004w. [DOI] [PubMed] [Google Scholar]
- 22.Gandhi S, Roy I. Synthesis and characterization of manganese ferrite nanoparticles, and its interaction with bovine serum albumin: A spectroscopic and molecular docking approach. J. Mol. Liq. 2019;296:111871. doi: 10.1016/j.molliq.2019.111871. [DOI] [Google Scholar]
- 23.Ahmad F, Zhou Y, Ling Z, Xiang Q, Zhou X. Systematic elucidation of interactive unfolding and corona formation of bovine serum albumin with cobalt ferrite nanoparticles. RSC Adv. 2016;6:35719–35730. doi: 10.1039/C6RA02850K. [DOI] [Google Scholar]
- 24.Poderys V, Matulionyte M, Selskis A, Rotomkis R. Interaction of water-soluble CdTe quantum dots with bovine serum albumin. Nanoscale Res. Lett. 2011;6:9. doi: 10.1007/s11671-010-9740-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Shao L, Dong C, Sang F, Qian H, Ren J. Studies on interaction of CdTe quantum dots with bovine serum albumin using fluorescence correlation spectroscopy. J. Fluoresc. 2009;19:151–157. doi: 10.1007/s10895-008-0396-0. [DOI] [PubMed] [Google Scholar]
- 26.Tian M, et al. Peptide-mediated synthesis of zeolitic imidazolate framework-8: Effect of molecular hydrophobicity, charge number and charge location. Nanomaterials. 2021;11:2665. doi: 10.3390/nano11102665. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Schejn A, et al. Controlling ZIF-8 nano- and microcrystal formation and reactivity through zinc salt variations. CrystEngComm. 2014;16:4493–4500. doi: 10.1039/C3CE42485E. [DOI] [Google Scholar]
- 28.Hu Y, Kazemian H, Rohani S, Huang Y, Song Y. In situ high pressure study of ZIF-8 by FTIR spectroscopy. Chem. Commun. 2011;47:12694–12696. doi: 10.1039/c1cc15525c. [DOI] [PubMed] [Google Scholar]
- 29.Park KS, et al. Exceptional chemical and thermal stability of zeolitic imidazolate frameworks. Proc. Natl. Acad. Sci. U.S.A. 2006;103:10186–10191. doi: 10.1073/pnas.0602439103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Shahabadi N, Maghsudi M, Rouhani S. Study on the interaction of food colourant quinoline yellow with bovine serum albumin by spectroscopic techniques. Food Chem. 2012;135:1836–1841. doi: 10.1016/j.foodchem.2012.06.095. [DOI] [PubMed] [Google Scholar]
- 31.Rajeshwari A, et al. Spectroscopic studies on the interaction of bovine serum albumin with Al2O3 nanoparticles. J. Lumin. 2014;145:859–865. doi: 10.1016/j.jlumin.2013.08.073. [DOI] [Google Scholar]
- 32.Gandhi S, Issar S, Mahapatro AK, Roy I. Cobalt ferrite nanoparticles for bimodal hyperthermia and their mechanistic interactions with lysozyme. J. Mol. Liq. 2020;310:113194. doi: 10.1016/j.molliq.2020.113194. [DOI] [Google Scholar]
- 33.Paul BK, Bhattacharjee K, Bose S, Guchhait N. A spectroscopic investigation on the interaction of a magnetic ferrofluid with a model plasma protein: Effect on the conformation and activity of the protein. Phys. Chem. Chem. Phys. 2012;14:15482–15493. doi: 10.1039/c2cp42415k. [DOI] [PubMed] [Google Scholar]
- 34.Sułkowska A. Interaction of drugs with bovine and human serum albumin. J. Mol. Struct. 2002;614:227–232. doi: 10.1016/S0022-2860(02)00256-9. [DOI] [Google Scholar]
- 35.Lakowicz JR. Principles of Fluorescence Spectroscopy. New York: Springer; 2007. [Google Scholar]
- 36.Ware WR. Oxygen quenching of fluorescence in solution: An experimental study of the diffusion process. J. Phys. Chem. 1962;66:455–458. doi: 10.1021/j100809a020. [DOI] [Google Scholar]
- 37.Liu J, Tian JN, Zhang J, Hu Z, Chen X. Interaction of magnolol with bovine serum albumin: A fluorescence-quenching study. Anal. Bioanal. Chem. 2003;376:864–867. doi: 10.1007/s00216-003-1964-4. [DOI] [PubMed] [Google Scholar]
- 38.Pawar SK, Jaldappagari S. Interaction of repaglinide with bovine serum albumin: Spectroscopic and molecular docking approaches. J. Pharm. Anal. 2019;9:274–283. doi: 10.1016/j.jpha.2019.03.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.De-Llanos R, Sánchez-Cortes S, Domingo C, García-Ramos JV, Sevilla P. Surface plasmon effects on the binding of antitumoral drug emodin to bovine serum albumin. J. Phys. Chem. C. 2011;115:12419–12429. doi: 10.1021/jp111683c. [DOI] [Google Scholar]
- 40.Sillen A, Engelborghs Y. The correct use of “average” fluorescence parameters. Photochem. Photobiol. 1998;67:475–486. [Google Scholar]
- 41.Cacita N, Nikolaou S. Studying the interaction between trinuclear ruthenium complexes and human serum albumin by means of fluorescence quenching. J. Lumin. 2016;169:115–120. doi: 10.1016/j.jlumin.2015.08.066. [DOI] [Google Scholar]
- 42.Li D, Zhu M, Xu C, Ji B. Characterization of the baicalein–bovine serum albumin complex without or with Cu2+ or Fe3+ by spectroscopic approaches. Eur. J. Med. Chem. 2011;46:588–599. doi: 10.1016/j.ejmech.2010.11.038. [DOI] [PubMed] [Google Scholar]
- 43.Baral A, Satish L, Das DP, Sahoo H, Ghosh MK. Construing the interactions between MnO2 nanoparticle and bovine serum albumin: Insight into the structure and stability of a protein-nanoparticle complex. New J. Chem. 2017;41:8130–8139. doi: 10.1039/C7NJ01227F. [DOI] [Google Scholar]
- 44.Temboot P, Usman F, Ul-Haq Z, Khalil R, Srichana T. Biomolecular interactions of amphotericin B nanomicelles with serum albumins: A combined biophysical and molecular docking approach. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2018;205:442–456. doi: 10.1016/j.saa.2018.07.057. [DOI] [PubMed] [Google Scholar]
- 45.Wang YX, Li L, Sheng LJ, Song GW, Xu ZS. Spectroscopic study on the inherent binding information of cationic perfluorinated surfactant with bovine serum albumin. J. Fluor. Chem. 2011;132:489–494. doi: 10.1016/j.jfluchem.2011.05.003. [DOI] [Google Scholar]
- 46.Alhazmi HA. FT-IR spectroscopy for the identification of binding sites and measurements of the binding interactions of important metal ions with bovine serum albumin. Sci. Pharm. 2019;87:5. doi: 10.3390/scipharm87010005. [DOI] [Google Scholar]
- 47.Zhuang J, et al. Optimized metal–organic framework nanospheres for drug delivery: Evaluation of small-molecule encapsulation. ACS Nano. 2014;8:2812–2819. doi: 10.1021/nn406590q. [DOI] [PubMed] [Google Scholar]
- 48.Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ. PatchDock and SymmDock: Servers for rigid and symmetric docking. Nucleic Acids Res. 2005;33:W363–W367. doi: 10.1093/nar/gki481. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request.